4//SEC Filing
Pelletier Nadege 4
Accession 0001104659-24-001167
CIK 0001828185other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 8:56 AM ET
Size
6.0 KB
Accession
0001104659-24-001167
Insider Transaction Report
Form 4
Pelletier Nadege
Chief Scientific Officer
Transactions
- Award
Share Option (Right to Buy)
2024-01-02+105,000→ 105,000 totalExercise: $3.70Exp: 2034-01-02→ Ordinary Shares (105,000 underlying)
Footnotes (2)
- [F1]The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 2, 2025.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
Barinthus Biotherapeutics plc.
CIK 0001828185
Entity typeother
Related Parties
1- filerCIK 0001965689
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 8:56 AM ET
- Size
- 6.0 KB